Child With Stevens-Johnson Syndrome Associated With PCR-Confirmed Adenovirus Infection

Abstract

Get full access to this article

View all access options for this article.

References

Alerhand

Cassella

Koyfman

. Stevens-Johnson syndrome and toxic epidermal necrolysis in the pediatric population: a review. Pediatr Emerg Care. 2016;32(7):472-476. doi:10.1097/PEC.0000000000000840.

Naegele

Sekula

Paulmann

Mockenhaupt

. Incidence of epidermal necrolysis: results of the German registry. J Invest Dermatol. 2020;140(12):2525-2527. doi:10.1016/j.jid.2020.03.968.

Ramien

Goldman

. Pediatric SJS-TEN: where are we now? F1000Res. 2020;9:F1000 Faculty Rev-982. doi:10.12688/f1000research.20419.1.

Levi

Bastuji-Garin

Mockenhaupt

, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009;123(2):e297-e304. doi:10.1542/peds.2008-1923.

Arantes

Reis

Novaes

Carvalho

Göttems

LBD

Novaes

MRCG

. Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals. An Bras Dermatol. 2017;92(5):661-667. doi:10.1590/abd1806-4841.20176610.

Quirke

Beck

Gamelli

Mosier

. A 15-year review of pediatric toxic epidermal necrolysis. J Burn Care Res. 2015;36(1):130-136. doi:10.1097/BCR.0000000000000208.

Khor

Lim

Tan

, et al. HLA-A*31:01 and HLA-B*15:02 association with Stevens–Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population. Pharmacogenet Genomics. 2017;27(7):275-278. doi:10.1097/FPC.0000000000000287.

Lalosevic

Nikolic

Gajic-Veljic

Skiljevic

Medenica

. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience. Int J Dermatol. 2015;54(8):978-984. doi:10.1111/ijd.12702.

Yamane

Matsukura

Watanabe

, et al. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients—treatment and outcome. Allergol Int. 2016;65(1):74-81. doi:10.1016/j.alit.2015.09.001.

10.

Léauté-Labrèze

Lamireau

Chawki

Maleville

Taïeb

. Diagnosis, classification, and management of erythema multiforme and Stevens–Johnson syndrome. Arch Dis Child. 2000;83(4):347-352. doi:10.1136/abc.83.4.347.

11.

Mazori

Nagarajan

Glick

. Recurrent reactive infectious mucocutaneous eruption (RIME): insights from a child with three episodes. Pediatr Dermatol 2020;37(3):545-547. doi:10.1111/pde.14142.

12.

Pohjanpelto

Pettay

. Isolation of adenovirus from a skin vesicle and cerebrospinal fluid from a patient suffering from Stevens-Johnson syndrome. Acta Pathol Microbiol Scand. 1967;70(4):632.

13.

Ting

Adam

. Stevens-Johnson syndrome: a review of 34 cases. Int J Dermatol 1985;24(9):587-591. doi:10.1111/j.1365-4362.1985.tb05857.x.

14.

Ström

. Aetiology of febrile mucocutaneous syndromes with special reference to the provocative role of infections and drugs. Acta Med Scand. 1977;201(1–2):131-136.

15.

Kiernan

Schanzlin

Leveille

. Stevens-Johnson syndrome associated with adenovirus conjunctivitis. Am J Ophthalmol. 1981;92(4):543-545. doi:10.1016/0002-9394(81)90648-6.

16.

Ström

. Febrile Mucocutaneous syndromes (ectodermosis erosive pluriorificialis, stevens-johnson syndrome etc.) in adenovirus infections. Acta Derm Venereol. 1967;47:281-286.

17.

Cremer

Hoffman

Lennette

. Analysis of antibody assay methods and classes of viral antibodies in serodiagnosis of cytomegalovirus infection. J Clin Microbiol. 1978;8(2):153-159.

18.

Gámez-González

Peña-Varela

Ramírez-López

Yamazaki-Nakashimada

. Adenoviral-induced rash and mucositis: expanding the spectrum of reactive infectious mucocutaneous eruption. Pediatr Dermatol. 2020;38:306–308. doi:10.1111/pde.14419.

19.

Canavan

Mathes

Frieden

Shinkai

. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol. 2015;72(2):239-245. doi:10.1016/j.jaad.2014.06.026.

20.

Paulmann

Mockenhaupt

. Fever in Stevens–Johnson syndrome and toxic epidermal necrolysis in pediatric cases. Pediatr Infect Dis J 2017;36(5):513-515. doi:10.1097/INF.0000000000001571.

21.

Pillay

Fernando

. The importance of distinguishing mycoplasma pneumoniae-induced rash and mucositis (MIRM) and Stevens-Johnson syndrome in a clinical setting. Hematol Med Oncol. 2020;5:1-3. doi:10.15761/HMO.1000209.

22.

Sassolas

Haddad

Mockenhaupt

, et al. ALDEN, an algorithm for assessment of drug causality in Stevens–Johnson Syndrome and toxic epidermal necrolysis: comparison with case–control analysis. Clin Pharmacol Ther. 2010;88(1):60-68. doi:10.1038/clpt.2009.252.

23.

High

WA.

Stevens-Johnson syndrome and toxic epidermal necrosis: pathogenesis, clinical manifestations and diagnosis (ed Adkinson

Levy

Mockenhaupt

Cronona

). UpToDate. Published 2023. Accessed June 2023. https://www.uptodate.com/contents/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis?search=23.%09High%20W.A.%20(2023).%20Stevens-Johnson%20syndrome%20and%20toxic%20epidermal%20necrosis:%20Pathogenesis,%20clinical%20manifestations%20and%20diagnosis.%20In%20N.F.%20Adkinson,%20M.L.%20Levy,%20M.%20Mockenhaupt,%20R.%20Cronona%20(Eds.),%20UpToDate.%20Available%20from&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2.

24.

Aberle

Steininger

Matthes-Martin

Pracher

Popow-Kraupp

. Adenovirus DNA in serum of children hospitalized due to an acute respiratory adenovirus infection. J Infect Dis. 2003;187(2):311-314. doi:10.1086/367808.